Latest News about SGEN
Recent news which mentions SGEN
   Why Shares of Zai Lab Limited Were Jumping on Tuesday
   
  
  
  September 05, 2023
  From Motley Fool
 
   Encouraging Data From Seagen/Genmab's Cervical Cancer Study - Tivdak Success Sets Stage For New Indications
   
  
  
  September 05, 2023
  From Benzinga
 
   3 Fantastic Stocks to Buy in a New Bull Market
   
  
  
  August 20, 2023
  From Motley Fool
 
   Seagen's Positive Trial Outcomes: Analyst Says The Update Might Double Tukysa's Current Market
   
  
  
  August 16, 2023
  From Benzinga
 
   Win For Pfizer? Seagen's Cancer Combo Therapy Hits Primary Goal In Late-Stage Breast Cancer Study
   
  
  
  August 16, 2023
  From Benzinga
 
   3 Cheap Long-Term Stocks That Smart Investors Will Snap Up Now
   
  
  
  August 06, 2023
  From InvestorPlace
 
   Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
   
  
  
  July 28, 2023
  From Benzinga
 From Motley Fool
 
   3 Pharma Stocks That AI is Loving in July
   
  
  July 13, 2023
  Tags
   Market News
   NASDAQ:CRSP,NYSE:PFE,NASDAQ:SGEN,NASDAQ:BEAM,NASDAQ:VRTX,NASDAQ:REGN,NASDAQ:NTLA
   PFE
  
  From InvestorPlace
 
   3 Healthcare Stocks With Healthy Dividends
   
  
  
  July 13, 2023
  From Motley Fool
 From MarketWatch
 
   From AI to Obesity Drugs - Global Pharma Has $700B For M&A and Investments: Goldman Sachs
   
  
  
  July 07, 2023
  From Benzinga
 From InvestorPlace
 
   The 7 Most Undervalued S&P 500 Stocks to Buy Now
   
  
  
  July 02, 2023
  From InvestorPlace
 From Benzinga
 From InvestorPlace
 
   Unlock the Potential of These 7 Cash-Flow Machines
   
  
  June 18, 2023
  Tags
   AVGO
   KO
   NASDAQ:AAPL,NASDAQ:AVGO,NYSE:CVX,NYSE:CAT,NYSE:ABBV,NYSE:PFE,NASDAQ:SGEN,NASDAQ:PEP,NYSE:KO
  
  From InvestorPlace
 
   Investor Opportunities Ahead of Clinical Updates, Says Analyst Initiating Coverage on Ambrx Biopharma with 'Buy' Rating
   
  
  
  June 14, 2023
  From Benzinga
 
   Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma Setting
   
  
  
  June 13, 2023
  From Benzinga
 From InvestorPlace
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.